Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.41326 | 55 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.20271 | 50 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.30289 | 53 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.18941 | 51 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.2212 | 52 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.54771 | 57 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.45358 | 55 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.33572 | 54 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.24977 | 52 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.26818 | 53 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.32078 | 54 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.21388 | 52 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.37022 | 55 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.31273 | 53 |